Vimian Group
25.00 SEK
-3.25 %
Less than 1K followers
VIMIAN
NASDAQ Stockholm
Health Care Providers
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-3.25 %
-6.09 %
-17.60 %
-13.19 %
-17.33 %
-38.04 %
+13.24 %
-
-68.09 %
Vimian Group is a group operating in animal health. The company, through its subsidiaries, delivers pharmaceuticals and technical solutions to veterinarians, laboratories and pet owners. The products include, for example, pharmaceuticals with associated clinical research and digital platforms for veterinary clinics. The company operates on a global level with headquarters in Stockholm.
Read moreMarket cap
13.23B SEK
Turnover
8.63M SEK
Revenue
4.59B
EBIT %
15.72 %
P/E
38.57
Dividend yield-%
-
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
29/4
2026
Interim report Q1'26
29/4
2026
General meeting '26
17/7
2026
Interim report Q2'26
All
Research
Webcasts
Press releases
ShowingAll content types
Vimian Group, Audiocast, Q4'25
Vimian’s year-end report for 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools